Clinical research has identified hyperglycemia (high blood glucose or blood sugar) as a factor that increases length of stay, hospital complications, and even inpatient mortality. The inpatient program is designed to meet current national standards for glycemic control in hospitalized patients, for those with known diabetes, and those with newly identified hyperglycemia. The team can initiate insulin therapy in the hospital if appropriate, teaching all the necessary skills for independent management. The team of endocrinologists and nurse practitioners follow patients throughout their stay. The goal of the program is to improve the transition from inpatient care to outpatient care while designing an individualized regimen.
Important Announcements
Nondiscrimination Statement Update
Boston Medical Center Health System complies with applicable Federal civil rights laws and does not discriminate on the basis of age, race, color, national origin (including limited English proficiency and primary language), religion, culture, physical or mental disabilities, socioeconomic status, sex, sexual orientation and gender identity and/or expression. BMCHS provides free aids and services to people with disabilities and free language services to people whose primary language is not English.
To see our full nondiscrimination statement, click here.
Campus Construction Update
Starting September 14, we’re closing the Menino building lobby entrance. This, along with the ongoing Yawkey building entrance closure, will help us bring you an even better campus experience that matches the exceptional care you've come to expect. Please enter the Menino and Yawkey buildings through the Moakley building, and make sure to leave extra time to get to your appointment. Thank you for your patience.
Click here to learn more about our campus redesign.
Popular Searches